Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program

— Contract Focused on Making DNA Data Storage Commercially Accessible — SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA [...]

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery

SOUTH SAN FRANCISCO, Calif.–Jan. 15, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ [...]

Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform for Next Generation Antibody Discovery

Additional Resources Will Support New Product Development and Global Expansion Salt Lake City, Utah, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners. The additional funding will support the continued adoption of the [...]

Congenica launches new application to enable faster analysis of epilepsy and neurodevelopmental disorders

Cambridge, United Kingdom  – Congenica, a digital health company enabling rapid analysis of complex genomic data to improve disease characterization and diagnosis, today announced the launch of Congenica Neuro™, a new application on its clinical decision support platform that facilitates faster, more accurate and comprehensive characterization and diagnosis of epilepsy and neurodevelopmental disorders. Collectively, around 300 million people [...]

Optimized Instruments for Polymer Characterization & Particle Sizing

Testa Analytical Solutions e.K, a leading developer of high-performance GPC / SEC instruments and detectors for polymer characterization will showcase its OEM design and manufacture capabilities at Analytica 2020. Backed by decades of experience, Testa Analytical has created, for a growing number of leading international laboratory and process instrument companies, fully optimised high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products [...]

Advanced BioMatrix Acquires HyStem® from Lineage Cell Therapeutics

Pictured Thiolated Hyaluronic Acid Kits for 3D Hydrogels. Advanced BioMatrix acquires HyStem® technology for R&D market Technology highly synergistic with existing Advanced BioMatrix products Advanced BioMatrix to fully manufacture and distribute the HyStem® kits California, USA – Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan. HyStem® [...]

Particle Testing Authority announces a comprehensive contract testing service for additive manufacturing powders

Complete solution for physical characterization backed by established application expertise Norcross, GA  – Particle Testing Authority, Micromeritics’ ISO17025 accredited contract testing laboratory today announced a comprehensive physical characterization service for the additive manufacturing (AM) industry that provides fast and efficient access to the techniques routinely used to optimize process performance and the attributes of finished [...]

seqWell to Expand Product Portfolio with $9M Series B Financing

BEVERLY, Mass. — seqWell has announced the close of a $9M Series B financing round with the goal of rapidly expanding its portfolio of genomics products into new areas such as single-cell genomics and transcriptomics. The company continues to drive its plexWell™ multiplexed library prep product offerings in growing markets such as high-throughput low-pass and targeted genotyping.  [...]

OGT unveils reliable somatic CNV detection for CLL with new NGS panel

SureSeq™ CLL + CNV – comprehensive CLL genomic profiling from a single assay Oxford, UK – 14 January 2020. Oxford Gene Technology (OGT), A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing (NGS) offering for research into Chronic Lymphocytic Leukaemia (CLL). The SureSeq CLL + [...]

Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applications

Company continues to advance academic and industry access to precise CRISPR-based synthetic reagents for rapid clinical research and development across disease areas REDWOOD CITY, California – Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice (GMP) standards to provide academic and industry partners with high-quality reagents for use in clinical research and development [...]

Access IBO on Knowledge Center
Register for Free Trial Login for Access

Register for Free Trial Login for Access

Lost your password? Register